PTEN and colorectal carcinoma: Focusing on non-synonymous single nucleotide substitutions in PTEN for the combined cohort (excluding MSS-htmb samples, comprising ~0.7% of the total, as too small a cohort to yield significant conclusions), we compared the observed frequency of mutations, versus the predicted frequency based on the occurrence of mutational signatures common in CRC (Supplementary Table S6).